New developments in cardiac surgery.

Francis Wellens; Jacques Goldstein; Belgian Association for Cardiac Surgery

Home/Archive/PubMed

PubMed · 15291433

New developments in cardiac surgery.

Francis Wellens·Jacques Goldstein·Belgian Association for Cardiac Surgery

View original source ↗Export metadata ↓

Abstract

In cardiac surgery new developments in the current area are mainly directed towards minimally invasive surgery techniques. New anastomotic devices for CABG are clinically available and will facilitate partial and total endoscopic CABG techniques. In valve surgery percutaneous techniques are already available for AVR and PVR. Single percutaneous mitral valve repair is not a too far away procedure. Tissue engineering will offer biocompatible heart valves. New developments for heart failure therapy are booming. The major drawback for the achievements of this amazing progress is the financial cost. An open debate between all the parties concerned in healthcare is urgently needed in order to maintain the quality of surgical care for the decades to come.

Explore related subjects

Coronary Artery Bypass Forecasting Genetic Therapy Heart Diseases Heart Failure Heart Valve Diseases Humans Minimally Invasive Surgical Procedures Thoracic Surgery Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Francis Wellens, Jacques Goldstein, Belgian Association for Cardiac Surgery. 2004. New developments in cardiac surgery.. https://pubmed.ncbi.nlm.nih.gov/15291433/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Invited commentary.

Explore the source record for details and available documents.

Coronary Artery Bypass↗

PubMed2007

Surgical damage of the saphenous vein and graft patency.

Explore the source record for details and available documents.

Coronary Artery Bypass↗

PubMed2007

Current trends in coronary artery disease in women.

PURPOSE OF REVIEW: There are some striking sex differences regarding presentation, symptoms and sign, diagnosis, and treatment of coronary artery disease. Historically, healthcare delivery to women has been plagued with treatment bias favoring men. This review will present relevant cardiovascular physiologic sex differences, current treatment options for coronary artery disease both surgical and medical, and clinical outcomes of such treatments. RECENT FINDINGS: In the past, pharmacologic and interventional studies generally excluded women from their subjects. As a result, women have been traditionally treated based on the findings in their male counterparts. Recent studies examining sex differences in the treatment of coronary artery disease have given new insight into the hormonal and behavioral influences associated with coronary artery disease. Finally, these studies have drawn attention to possibly inadvertent discrepancies in the way men and women are treated for coronary artery disease. SUMMARY: Despite significant advances in medical and surgical approaches to treat coronary artery disease, it remains and will continue to be the most important healthcare challenge of the 21st century. Whereas efforts are underway to encourage inclusion of more women in therapeutic trials, the educational process, particularly in medical school, needs to broadly address sex specific pathophysiology and treatment, rather than relying on sub-subspecialty training for optimizing healthcare delivery in women.

Coronary Artery Bypass↗